Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing. The startup aims to scale production and expand its organoid technology, offering a more human-relevant platform for drug development. This move aligns with growing regulatory pressure to reduce reliance on animal models in pharmaceutical testing.